Table 2.
Comparative outcomes for advanced-stage NLPHL treatments
N/R indicates not reported; COPP, cyclophosphamide, vincristine, procarbazine, prednisone; IMEP, ifosfamide, methotrexate, etoposide, prednisone; and BEACOPP, bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone.
